Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humansIan D. Davis, Jonathan Cebon, Qiyuan Chen et al.|Proceedings of the National Academy of Sciences|2004Cited by 440
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUğur Eskiocak, Sean J. Morrison, Vijayashree Ramesh et al.|Nature Communications|2016Cited by 69
Prospective isolation according to melanin pigment content of melanoma cells with heterogeneous potentials for disease propagationClare G. Fedele, Mark Shackleton|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1